Portfolio AOP Health
Product overview with focus on integrated therapies for rare diseases and in critical care.
AOP Health's focus is on integrated therapies for rare diseases and in critical care. The portfolio comprises products in the following therapeutic areas: Hemato-oncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders and Critical Care. AOP Health’s strategic goal is to constantly deliver new treatment options with respect to rare diseases and critical care.
- United Arab Emirates
- Czech Republic
- United Kingdom
Naltrexone Amomed is used as an additional therapeutic tool in a comprehensive treatment including a psychotherapeutic program for patients suffering from opioid dependence
Rapibloc belongs to a group of drugs called "beta blockers". This medicine is used in adults to treat heart problems when it is getting too fast. It is used during or immediately after an interventional surgery or other situations when a control of the heartbeat is needed.
Reverpleg is an artificially produced active substance equivalent to vasopressin natural hormone. It regulates the body's balance of water and reduces urinary excretion. Reverpleg is used in septic shock states after unsuccessful use of other appropriate methods to achieve target values of the blood pressure set by physicians.
Treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) for improving exercise capacity and alleviate disease symptoms in patients with New York Heart Association (NYHA) Functional Class III.